DNMT1 and colonic neoplasm: Of interest, several strategies have been proposed as alternative therapeutic pathways to increase the expression of HCAR2 in colon cancer; the concomitant administration of SCFAs with DNMT inhibitors, such as procainamide, [81] as well as the administration of natural products such as